These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 12698078

  • 21. Combined FTY720/cyclosporine A treatment promotes graft survival and lowers the peripheral lymphocyte count in DA to lewis heart and skin transplantation models.
    Nikolova Z, Hof A, Baumlin Y, Hof RP.
    Transpl Immunol; 2001 Feb; 8(4):267-77. PubMed ID: 11316070
    [Abstract] [Full Text] [Related]

  • 22. Cyclosporine treatment of high dose and long duration reduces the severity of graft coronary artery disease in rodent cardiac allografts.
    Lijkwan MA, Cooke DT, Martens JM, Kown MH, Murata S, Peterson SH, Hoyt EG, Robbins RC.
    J Heart Lung Transplant; 2005 Apr; 24(4):439-45. PubMed ID: 15797746
    [Abstract] [Full Text] [Related]

  • 23. Control of intestinal allograft rejection by FTY720 and costimulation blockade.
    Yan S, Rodriguez-Barbosa JI, Pabst O, Beckmann JH, Brinkmann V, Förster R, Hoffmann MW.
    Transplant Proc; 2005 Apr; 37(1):114-5. PubMed ID: 15808565
    [Abstract] [Full Text] [Related]

  • 24. Inhibition of graft coronary arteriosclerosis after heart transplantation.
    Soukiasian HJ, Czer LS, Wang HM, Luthringer D, Wang C, Kamlot A, Quartel A, Trento A.
    Am Surg; 2004 Oct; 70(10):833-40. PubMed ID: 15529833
    [Abstract] [Full Text] [Related]

  • 25. Foetal rat pancreatic transplantation: posttransplantation development of foetal pancreatic iso- and allografts and suppression of rejection with mycophenolate mofetil (MMF) and cyclosporine based immunesuppression.
    du Toit D, Muller C, Page B, Louw J.
    Microsc Res Tech; 1998 Nov 15; 43(4):347-55. PubMed ID: 9849976
    [Abstract] [Full Text] [Related]

  • 26. FTY720 immunomodulation: optimism for improved transplant regimens.
    Ferguson R.
    Transplant Proc; 2004 Mar 15; 36(2 Suppl):549S-553S. PubMed ID: 15041404
    [Abstract] [Full Text] [Related]

  • 27. FTY720, a new immunosuppressant, as rescue therapy in mouse cardiac transplantation.
    Wang MH, Milekhin V, Zhang H, Huang HZ.
    Acta Pharmacol Sin; 2003 Sep 15; 24(9):847-52. PubMed ID: 12956930
    [Abstract] [Full Text] [Related]

  • 28. Change from cyclosporine to combination therapy of mycophenolic acid with the new sphingosine-1-phosphate receptor agonist, KRP-203, prevents host nephrotoxicity and transplant vasculopathy in rats.
    Fujishiro J, Suzuki C, Kudou S, Yasue T, Hakamata Y, Takahashi M, Murakami T, Hashizume K, Kobayashi E.
    J Heart Lung Transplant; 2006 Jul 15; 25(7):825-33. PubMed ID: 16818126
    [Abstract] [Full Text] [Related]

  • 29. Early administration of FTY720 prevents chronic airway as well as vascular destruction in experimental rat lung transplantation.
    Hirt SW, von Suesskind-Schwendi M, Puehler T, Schmid C, Lehle K.
    Transplant Proc; 2013 Mar 15; 45(2):783-6. PubMed ID: 23498820
    [Abstract] [Full Text] [Related]

  • 30. Effect of FTY720 in rat small bowel transplantation: apoptosis of crypt cells and lymphocytes in gut-associated lymphoid tissues.
    Sugito K, Koshinaga T, Inoue M, Ikeda T, Hagiwara N, Kusafuka T, Fukuzawa M.
    Transplant Proc; 2006 Nov 15; 38(9):3058-60. PubMed ID: 17112899
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. FTY720 reduces extracellular matrix expansion associated with ischemia-reperfusion induced injury.
    Delbridge MS, Shrestha BM, Raftery AT, El Nahas AM, Haylor J.
    Transplant Proc; 2007 Dec 15; 39(10):2992-6. PubMed ID: 18089307
    [Abstract] [Full Text] [Related]

  • 33. FTY720 reduces T-cell recruitment into murine intestinal allograft and prevents activation of graft-infiltrating cells.
    Kimura T, Hasegawa T, Nakai H, Azuma T, Usui N, Sasaki T, Okada A.
    Transplantation; 2003 May 15; 75(9):1469-74. PubMed ID: 12792499
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Sinomenine blocks tissue remodeling in a rat model of chronic cardiac allograft rejection.
    Mark W, Schneeberger S, Seiler R, Stroka DM, Amberger A, Offner F, Candinas D, Margreiter R.
    Transplantation; 2003 Apr 15; 75(7):940-5. PubMed ID: 12698077
    [Abstract] [Full Text] [Related]

  • 36. The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-BETA expression.
    Rintala JM, Savikko J, Rintala SE, von Willebrand E.
    Transplant Proc; 2006 Dec 15; 38(10):3239-40. PubMed ID: 17175234
    [Abstract] [Full Text] [Related]

  • 37. How cyclosporine modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts.
    Koskinen PK, Lemström KB, Häyry PJ.
    Am J Pathol; 1995 Apr 15; 146(4):972-80. PubMed ID: 7536397
    [Abstract] [Full Text] [Related]

  • 38. FTY720: early clinical experience.
    Dragun D, Fritsche L, Boehler T, Peters H, Budde K, Neumayer HH.
    Transplant Proc; 2004 Mar 15; 36(2 Suppl):544S-548S. PubMed ID: 15041403
    [Abstract] [Full Text] [Related]

  • 39. Skin allograft survival and analysis of renal parameters after FTY720 + tacrolimus treatment in mice.
    Lopes CT, Gallo AP, Palma PV, Cury PM, Bueno V.
    Transplant Proc; 2008 Apr 15; 40(3):856-60. PubMed ID: 18455036
    [Abstract] [Full Text] [Related]

  • 40. FTY720, a novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine A.
    Hoshino Y, Suzuki C, Ohtsuki M, Masubuchi Y, Amano Y, Chiba K.
    Transplant Proc; 1996 Apr 15; 28(2):1060-1. PubMed ID: 8623226
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.